Insmed Stock Catapults On Rumored Sanofi Deal; Could Biotech See Its Biggest Transaction In Years?
Key Points:
- Investor’s Business Daily (IBD) provides information for educational purposes only and does not offer investment advice or recommendations.
- The data presented is sourced from reliable providers but IBD does not guarantee its accuracy, timeliness, or suitability.
- Past investment performance shared by IBD is not indicative of future results, and authors may hold stocks they discuss.
- Use of IBD’s services is governed by their Terms of Use, and all information is subject to change without notice.
- IBD and related marks are registered trademarks of Investor’s Business Daily, LLC, with real-time pricing sourced primarily from Nasdaq Last Sale and other data providers.